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The workshop upon which these proceedings are based
was designed with three objectives in mind: 1) to review
the current state of reproductive research employing the
assisted reproductive technologies (ARTs) in non-human
primates (NHPs), including both basic concepts and spe-
cific applications; 2) to enhance interactions and collabo-
rative efforts within and between National Primate
Research Centers (NPRC) and academic institutions con-
cerning these technologies and reproductive research; and
3) to identify and discuss new developments in reproduc-
tive physiology, gamete/embryo biology and efforts to
exploit the ARTs in nonhuman primate species. Our
underlying premise is the understanding that NHPs have,
and should continue to play a significant role in biomed-
ical research by offering a biological substratum remarka-
bly similar to that of the human species, that is, they
represent a clinically relevant model. Of course, the
impact that research with NHPs will have on the overall
understanding of the pathophysiology and treatment of
human diseases is dependent upon animal availability
and here it is assumed that meeting the NHP needs of the
biomedical research community will require the use of the
ARTs.
Unlike in many fields where knowledge flows from NHP
research to clinical application in humans, the develop-
ment of the ARTs in NHPs historically postdates human
application. The ARTs have been perfected for the treat-
ment of human infertility and as practiced clinically, have
seen rapid advances in many areas including ovarian fol-
licular stimulation, treatment of male infertility by intrac-
ytoplasmic sperm injection (ICSI) with ejaculated,
epididymal or testicular sperm (both fresh and frozen),
culture medium development for the production of blast-
ocysts, low temperature storage of sperm and embryos
and non-surgical embryo transfer at the blastocyst stage.
The experience in macaques, while nowhere nearly as
extensive, has been associated with several landmark
accomplishments and the methods for establishing preg-
nancies were reviewed in this workshop.
The ARTs in NHPs carry the potential to impact diverse
areas in biomedical research and several examples were
considered. The availability of NHP embryos has sup-
ported the isolation of embryonic stem cells raising the
possibility of cell-based therapy for the treatment of
human degenerative diseases. Many of these applications
will undoubtedly be previewed in the NHP and several
presentations at this workshop addressed translational
research efforts in NHPs in this newly emerging field of
regenerative medicine.
With an estimated 33 million individuals in the world
infected with the AIDS virus, the need for an effective vac-
cine is recognized as one of the highest priorities of the
biomedical research community, yet the supply of Indian-
origin, Mamu-A*01 positive, rhesus macaques for vaccine
development studies is grossly inadequate. The ARTs can
significantly impact this shortage based on the ability to
propagate a founder animal of defined MHC genotype.
An even greater need in the vaccine development or tissue
transplantation fields where immune system function is
under study, is access to genetically-identical animals.
Progress in somatic cell cloning and monozygotic twin-
ning was summarized in this workshop.
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Although fertility control is an issue of global and
national public health concern, little progress has been
made toward the development of new birth control meth-
ods. NHPs of Old World origin are the ideal species in
which to pursue development of novel contraceptive
methods because of the similarity of their menstrual
cycles and reproductive organs to those of women. Recent
advances in cell biology were summarized that have led to
the elucidation of novel mechanisms that can be targeted
to specific sites in the reproductive tract for contraceptive
development.
Neurogenetic diseases cause tens of thousands of deaths
in the United States each year, inflict immeasurable pain
and suffering, and consume a substantial portion of scarce
healthcare resources. A mouse counterpart for many of
these human diseases does not exist necessitating the cre-
ation and use of new animal models that in some cases
can only be served by NHPs. The ARTs can be used to cre-
ate these disease models employing a combination of
gene targeting and somatic cell nuclear transfer. Thus,
gene targeting would first be conducted in cell lines that
subsequently serve as the source of nuclei for cloning.
Embryos created by nuclear transfer from these targeted
nuclei and then transferred into surrogate mothers could
provide a reliable source of affected, genetically-modified
infants for the study of human neurogenetic diseases.
Progress in gene targeting and somatic cell cloning, the
prerequisite technologies to create genetically-modified
monkeys, are summarized in the workshop proceedings.
In summary, we believe that a NHP model is essential in
efforts to study human health with direct implications to
biomedical investigations of infertility and contraception,
infectious diseases and vaccine development, drug and
alcohol addiction, neurological disorders and regenera-
tive medicine using gene-, stem cell and tissue-based ther-
apies. Despite significant advances in the past decade, the
ARTs in NHPs, while potentially very useful have yet to be
realized on a scale adequate to impact the needs described
above. We hope that the proceedings of this workshop
will contribute in a significant way to the intelligent and
expanded use of the valuable NHP animal model in bio-
medical research.